Abstract
Amisulpride, a selective antagonist of D2 and D3 dopamine receptors, is used as an antipsychotic drug. In this study, we reported a sensitive LC–MS/MS method for determining amisulpride concentrations in rat plasma, and a preclinical pharmacokinetic study in the rat. After a simple protein precipitation with acetonitrile containing methaqualone as an internal standard, the analytes were separated on a reversed-phase column with a mobile phase of 0.2 % aqueous formic acid and acetonitrile (3:7, v/v). The accuracy and precision of the assay were in accordance with FDA guidance for the validation of bioanalytical methods. This analytical method was used successfully to characterize the time course of the plasma concentration of amisulpride following oral administration of a single 10 mg/kg dose in rats.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ascalone, V., M. Ripamonti, and B. Malavasi. 1996. Stereospecific determination of amisulpride, a new benzamide derivative, in human plasma and urine by automated solid-phase extraction and liquid chromatography on a chiral column. Application to pharmacokinetics. Journal of Chromatography B 676: 95–105.
El Ela, A.A., S. Härtter, U. Schmitt, C. Hiemke, H. Spahn-Langguth, and P. Langguth. 2004. Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds-implications for pharmacokinetics of selected substrates. Journal of Pharmacy and Pharmacology 56: 967–975.
Gschwend, M.H., P. Arnold, J. Ring, and W. Martin. 2006. Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring. Journal of Chromatography B 831: 132–139.
Kang, W. 2006. Simple and sensitive determination of nisoldipine in plasma using liquid chromatography–tandem mass spectrometry. Analytical Sciences 22: 1597–1599.
Kang, W. 2012. Quantitative determination of uridine in rabbit plasma and urine by liquid chromatography coupled to a tandem mass spectrometry. Biomedical Chromatography 26: 541–544.
Kratzsch, C., F.T. Peters, T. Kraemer, A.A. Weber, and H.H. Maurer. 2003. Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. Journal of Mass Spectrometry 38: 283–295.
Kudris, I.V., N.N. Skakun, I.N. Orlova, V.V. Libina, and A.U. Kulikov. 2011. Analysis of amisulpride in human plasma by SPE and LC with fluorescence detection. Chromatographia 73: 67–74.
Mogili, R., K. Kanala, B.R. Challa, B.R. Chandu, and C.K. Bannoth. 2011. Development and validation of amisulpride in human plasma by HPLC coupled with tandem mass spectrometry and its application to a pharmacokinetic study. Scientia Pharmaceutica 79: 583–599.
Mortimer, A.M. 2009. Update on the management of symptoms in schizophrenia: focus on amisulpride. Neuropsychiatric Disease and Treatment 5: 267–277.
Nirogi, R., G. Bhyrapuneni, V. Kandikere, K. Mudigonda, D. Ajjala, R. Suraneni, and K. Mukkanti. 2008. Liquid chromatography tandem mass spectrometry method for the quantification of amisulpride with LLOQ of 100 pg/mL using 100 microL of plasma. Biomedical Chromatography 22: 1424–1433.
Noh, K., K.S. Kim, B. Ahn, P. Archimbault, T.H. Oh, and W. Kang. 2012a. Simultaneous determination of zolazepam and tiletamine in dog plasma by liquid chromatography coupled to a tandem mass spectrometry. Biomedical Chromatography 26: 1133–1136.
Noh, K., J.H. Park, M. Kim, M. Jung, H.J. Lee, K.I. Kwon, W. Kang, and H. Ha. 2012b. Determination of daumone in mouse plasma by HPLC/MS–MS. Biomedical Chromatography 26: 152–155.
Péhourcq, F., S. Ouariki, and B. Bégaud. 2003. Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication. Journal of Chromatography B 789: 101–105.
Perrault, G., R. Depoortere, E. Morel, D.J. Sanger, and B. Scatton. 1997. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. Journal of Pharmacology and Experimental Therapeutics 280: 73–82.
Scatton, B., Y. Claustre, Y. Cudennec, A. Oblin, G. Perrault, D.J. Sanger, and H. Schoemaker. 1997. Amisulpride: from animal pharmacology to therapeutic action. International Clinical Psychopharmacology 12: S29–S36.
Schmitt, U., A. Abou El-Ela, L.J. Guo, H. Glavinas, P. Krajcsi, J.M. Baron, C. Tillmann, C. Hiemke, P. Langguth, and S. Härtter. 2006. Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp). Journal of Neural Transmission 113: 787–801.
Schoemaker, H., Y. Claustre, D. Fage, L. Rouquier, K. Chergui, O. Curet, A. Oblin, F. Gonon, C. Carter, J. Benavides, and B. Scatton. 1997. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. Journal of Pharmacology and Experimental Therapeutics 280: 83–97.
Acknowledgments
This research was supported by Yeungnam University research grant.
Conflict of interest
The authors declared no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Keumhan Noh and Yoo-Jeong Jang have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Noh, K., Jang, YJ., Kwon, Ki. et al. Quantitative determination of amisulpride in rat plasma by HPLC–MS/MS. Arch. Pharm. Res. 38, 63–67 (2015). https://doi.org/10.1007/s12272-014-0361-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-014-0361-1